WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MIRM past revenue growth

How has MIRM's revenue growth performed historically?
Company
141.85%
Industry
145.73%
Market
17.2%
MIRM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MIRM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MIRM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MIRM earnings and revenue history

Current Revenue
$186.4M
Current Earnings
-$163.4M
Current Profit Margin
-87.7%

MIRM Return on Equity

Current Company
-88.6%
Current Industry
-63.5%
Current Market
188%
MIRM's Return on Equity (-88.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MIRM announces earnings.

MIRM Return on Assets

Current Company
-31.5%
Current Industry
2.9%
MIRM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MIRM Return on Capital Employed

Current Company
-26.33%
Current Industry
19.5%
MIRM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MIRM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MIRM$186.37M-$135.87M-$163.42M+212.06%N/A
DAWN$0.00-$188.53M-$188.92MN/AN/A
FDMT$20.72M-$95.09M-$100.84M+7.96%N/A
MNKD$198.96M$20.62M-$11.94M+48.17%N/A
SYRE$886.00k-$337.85M-$338.79M-25.61%N/A
View Top Biotech Stocks

MIRM earnings dates

Next earnings date
Jun 5, 2024

Mirum Pharmaceuticals Earnings & Revenue FAQ

What were MIRM's earnings last quarter?

On Invalid Date, Mirum Pharmaceuticals (NASDAQ: MIRM) reported Q4 2023 earnings per share (EPS) of -$0.72, up 26.53% year over year. Total Mirum Pharmaceuticals earnings for the quarter were -$35.66 million. In the same quarter last year, Mirum Pharmaceuticals's earnings per share (EPS) was -$0.98.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.

What was MIRM's earnings growth in the past year?

As of Q2 2024, Mirum Pharmaceuticals's earnings has grown year over year. Mirum Pharmaceuticals's earnings in the past year totalled -$163.42 million.

What is MIRM's earnings date?

Mirum Pharmaceuticals's earnings date is Invalid Date. Add MIRM to your watchlist to be reminded of MIRM's next earnings announcement.

What was MIRM's revenue last quarter?

On Invalid Date, Mirum Pharmaceuticals (NASDAQ: MIRM) reported Q4 2023 revenue of $69.55 million up 149.24% year over year. In the same quarter last year, Mirum Pharmaceuticals's revenue was $27.91 million.

What was MIRM's revenue growth in the past year?

As of Q2 2024, Mirum Pharmaceuticals's revenue has grown 141.85% year over year. This is 3.88 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Mirum Pharmaceuticals's revenue in the past year totalled $186.37 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.